Charles Schwab Investment Management Inc

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-09
Total Holdings
3,541
Total Value
447180164965
Accession Number
0001752724-25-099334
Form Type
13F-HR
Manager Name
Charles Schwab Investment Management Inc
Data Enrichment
95% identified
3,366 identified175 unidentified

Holdings

3,541 positions
Manager:
Search and click to pin securities to the top
Page 170 of 174
United Homes Group, Inc.
Shares:
23396(+34.5%)
Value:
$65.5M(-11.0%)
Upland Software, Inc.
Shares:
22775(-0.1%)
Value:
$65.1M(-34.2%)
Coya Therapeutics, Inc.
Shares:
10000
Value:
$64.7M
Protara Therapeutics, Inc.
Shares:
15000
Value:
$63.9M
FibroBiologics, Inc.
Shares:
69805(+0.1%)
Value:
$62.8M(-55.0%)
Lument Finance Trust, Inc.
Shares:
24035(+0.0%)
Value:
$62.7M(+1.2%)
Vaxart, Inc.
Shares:
153547(+0.0%)
Value:
$62.5M(-38.5%)
Rithm Property Trust Inc.
Shares:
21666
Value:
$62.2M
CuriosityStream Inc.
Shares:
23041(+0.0%)
Value:
$61.8M(+75.2%)
Boundless Bio, Inc.
Shares:
40458(+0.0%)
Value:
$61.1M(-47.9%)
Vistagen Therapeutics, Inc.
Shares:
23302(+0.0%)
Value:
$58.3M(-15.3%)
PepGen Inc.
Shares:
40070(-17.1%)
Value:
$56.3M(-69.3%)
HARVARD BIOSCIENCE INC
Shares:
98883(-58.7%)
Value:
$56.0M(-88.9%)
GAN Ltd
Shares:
31476(+0.0%)
Value:
$55.7M(-2.7%)
TriSalus Life Sciences, Inc.
Shares:
10000
Value:
$55.2M
Neuronetics, Inc.
Shares:
15000
Value:
$55.2M
Tevogen Bio Holdings Inc.
Shares:
49644(+0.1%)
Value:
$53.6M(+5.0%)
WW INTERNATIONAL, INC.
Shares:
99577(+0.0%)
Value:
$52.0M(-58.9%)
Aclaris Therapeutics, Inc.
Shares:
33079(+0.0%)
Value:
$50.6M(-38.3%)
DiaMedica Therapeutics Inc.
Shares:
13253(+0.0%)
Value:
$50.2M(-30.2%)